Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline. | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function. | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders. | 5 - 10 | 2025 | $65,000,000 | ||
Rx Save Card is an innovative pharmacy benefit solution that allows businesses and employees to integrate an assortment of cost-cutting initiatives into one integrated navigation and payment experience. | Chicago | IL | 1 - 10 | 2024 | $1,700,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Responsive Arthroscopy is a medtech company that offers medical devices for the sports medicine field. | 10 - 50 | 2024 | $9,999,999 | ||
Z-Score Health is a forward-thinking healthcare company leveraging technology to offer personalized preventive care. Their approach integrates comprehensive health risk assessments using a sophisticated SaaS platform and mobile applications, focusing on areas like women's health, geriatric care, and sexual health. They emphasize patient satisfaction and convenience, aiming to make healthcare more accessible and effective through technology. This summary provides an essence of their services and mission; for a detailed description, you would need to refer to their official website or professional profile. | Atlanta | GA | 1 - 10 | 2024 | $600,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $602,600,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional AI tools that rely on manual prompting, DeltaGen’s no-prompt AI delivers highly accurate, deterministic insights with seamless integration. | 50 - 268 | 2024 | $2,700,000 | ||
PilloVR is a pioneering healthtech startup dedicated to transforming pediatric healthcare through virtual reality. Our mission is to make medical visits less stressful and more engaging for young patients by using immersive VR experiences as a distraction tool during procedures such as vaccinations and blood draws. With content designed specifically for children, PilloVR helps reduce anxiety and enhance the overall patient experience while also benefiting healthcare professionals by streamlining routine procedures. Currently being tested in over 50 clinics across the U.S., including renowned institutions like Harvard, Yale, and UC Irvine, PilloVR is setting a new standard for compassionate, innovative pediatric care. | 1 - 10 | 2024 | $3,000,000 | ||
Thrive AI Health builds an AI health coach. Thrive AI Health use generative AI to hyper-personalize and scale behavior change. | 10 - 50 | 2024 | $8,049,999 | ||
Offcall is tackling for physician burnout by providing salary and work transparency, along with financial education. | San Francisco | CA | 5 - 20 | 2024 | $2,000,000 |
Kabilah streamlines shift change for nurses with an AI-powered assistant that replaces paper reports. | Stanford | CA | 1 - 10 | 2024 | $500,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi. | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Lift Labs is a creator of a suite of home health hardware for people living with Parkinson's Disease and Essential Tremor. Its core R&D focuses on areas of healthcare, sustainability, safety, and education. The company was founded in 2010 and is headquartered in San Francisco, California. | San Francisco | CA | 5 - 10 | 2024 | $2,900,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs. | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members. | 10 - 50 | 2024 | $85,251,248 | ||
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | New York | NY | 10 - 50 | 2024 | $48,000,000 |
Trovo Health uses AI technology to provide comprehensive healthcare solutions, combining smart algorithms with professional human coaching to deliver personalized patient care. | New York | NY | 10 - 50 | 2024 | $15,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiple sequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | San Francisco | CA | 5 - 20 | 2024 | $101,000,000 |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area. | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages. | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Arini is an AI receptionist for dental practices that answers phone calls, and schedules appointments. | San Francisco | CA | 1 - 10 | 2024 | $500,000 |
C3 is a defense technology company developing novel solutions for medics. Built by Silent Ventures. | Ann Arbor | MI | 10 - 500 | 2024 | $55,000,000 |
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | Chicago | IL | 20 - 50 | 2024 | $20,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | 10 - 50 | 2024 | $13,000,000 | ||
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $40,000,000 |
Ply Health’s platform delivers a better and faster contracting and credentialing experience. Using our tech + automation and behavioral health expertise, we've been able to get providers in network with payers weeks to months faster than other vendors.
Ply Health partners with physical practices, digital practices, build-your-own-business platforms and new provider entrepreneurs in behavioral to magically simplify data collection, enrollment submission, follow ups and record keeping.
Ply Health is backed by YCombinator and is based in San Francisco. | San Francisco | CA | 5 - 10 | 2024 | $500,000 |
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. | 20 - 100 | 2024 | $300,000,000 | ||
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
Advancing healthcare through adaptable and innovative inventory management solutions. | Haddonfield | NJ | 1 - 10 | 2024 | $1,250,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London. | 2 - 10 | 2024 | $2,000,000 | ||
Oma Care is to empower, assist, and compensate people who care for our most vulnerable citizens—family caregivers. | San Francisco | CA | 2 - 10 | 2024 | $500,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machine Learning in order to improve clinical outcomes for complex and debilitating diseases such as endometriosis, infertility disorders, and genetic conditions that impact quality of life and longevity. | 1 - 10 | 2024 | |||
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
Our HIPAA-Compliant AI Assistant will save you hours of paperwork time a week. Summarize parent interviews, caregiver trainings, and RBT supervision. Automate insight extraction from client records. Generate huge parts of treatment plans.
Interested in trying it out? No credit card required. No client data needed. Sign up for free! | 1 - 10 | 2024 | |||
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $325,000,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Endo Health creates a gamified ''AI endocrinologist'' for type 2 diabetes management. They are creating a pleasant AI medical assistant that will walk patients through every stage of diabetic control, complete with gamified involvement. | San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
Sonologi, Inc. is a deep-tech startup based in Palo Alto, specializing in wearable ultrasound technology for continuous real-time imaging in critical care and remote monitoring. Our patches enable non-invasive, high-resolution imaging of multiple organs simultaneously, providing comprehensive patient data for better decision-making. Sonologi focus on applications in ICU, OR, emergency care, and remote monitoring, integrating AI for advanced image analysis and diagnostics. | Palo Alto | CA | 2 - 10 | 2024 | $2,500,000 |
careCycle is an AI workforce for Medicare agencies and FMOs, supporting top agencies in their operations. | 5 - 10 | 2024 | $2,000,000 | ||
AT4K specializes in and alone performs in-person autism evaluations. It is committed to reducing the time it takes for children to be evaluated for Autism Spectrum Disorder (ASD) and providing comprehensive and reliable evaluations that enable early intervention and individualized care. | Grapevine | TX | 10 - 50 | 2024 | $2,500,000 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 5 - 10 | 2023 | $6,500,000 |
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms. | Watertown | MA | 10 - 50 | 2023 | $65,000,000 |
Crop Diagnostix is a biotechnology company that uses RNA sequencing and AI for predictive agriculture. | San Diego | CA | 5 - 10 | 2023 | $3,577,993 |
Sonia is lowering the cost of mental health treatment to a fraction of what it is now and making it available to everyone, anytime, anywhere. The App Store now features the Sonia iOS app. | New York | NY | 500 - 1,000 | 2023 | |
Medication errors cost the healthcare industry $40 billion each year, the largest contributor being the manual processes employed by pharmacies. Wattson Health's automation platform integrates with pharmacies' existing systems and enables them to fill prescriptions error-free in a matter of seconds vs. hours or even days. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Shasta Health is a physical therapy center that offers patient acquisition, billing, care plans, and other care facilities. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Enabling women's health providers to start, grow, and operate their own practices. | Dover | DE | 2 - 10 | 2023 | $500,000 |
Flint is a global healthcare talent recruiting platform. Flint supports healthcare staffing needs. Flint sources nurses from around the globe, enabling clients to let the organization manage the entire recruiting, licensing, immigration, and relocation processes. | San Francisco | CA | 20 - 50 | 2023 | |
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company specializes in developing novel therapeutics that address underserved conditions including PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo Pharma operates in the United States. | Sarasota | FL | 3 | 2023 | $12,006,060 |
Tuesday Health empowers lives through supportive care by easing the symptoms and stress of serious illness. | Nashville | TN | 20 - 50 | 2023 | $60,000,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to use massive language models to create RNA-based medicinal therapies. | New York | NY | 20 - 50 | 2023 | $142,000,000 |
Nicer Inc provides training and development services. The Company offers automobile driving schools. | 5 - 10 | 2023 | $2,000,000 | ||
Knownwell operates as an Artificial Intelligence as a Service platform. | Haymarket | VA | 20 - 100 | 2023 | $30,500,000 |
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multiple therapeutic programs towards a new era of medicines. | 5 - 20 | 2023 | $10,000,000 | ||
Being Health is a psychiatrist-led mental health practice that leverages the best of psychiatry. | New York | NY | 10 - 50 | 2023 | $5,400,000 |
Accelerate Dental Holdings is a dental healthcare centre | Murray | UT | 10 - 50 | 2023 | $11,900,000 |
Humanaut Health operates as a company that provides health optimization and longevity. | Austin | TX | 20 - 50 | 2023 | $9,250,000 |
Aligned Marketplace operates as a personalized primary care for workforce. | New York | NY | 10 - 20 | 2023 | $11,000,000 |
Clearwave operates a healthcare network that allows medical facilities to authenticate insurance eligibility of patients. | 10 - 200 | 2023 | $5,295,884 | ||
Coral Care is a venture-backed company on a mission to help parents access the care they need to help their children thrive. | New York | NY | 20 - 50 | 2023 | $6,500,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
RapidClaims is redesigning the healthcare billing stack | New York | NY | 20 - 100 | 2023 | $11,100,000 |
RubyWell exists to ignite a new caregiving economy that fairly compensates all family caregivers.
Over 44 million adults are caring for at least one aging loved one. And the cost of providing that care runs each of them $7k annually, on average. It’s no surprise that the care of a loving family member or friend can improve the health, safety, and emotional well-being of an aging adult. But our healthcare system is benefiting from this labor of love, too. Namely, pharmaceutical companies and insurance providers.
The good news: smart healthcare leaders value the impact of family caregivers. And they’re partnering with RubyWell to help provide much needed savings and income to this hidden and vital workforce. The RubyWell platform gives all family caregivers the means to regain financial stability by unlocking unused Medicare benefits, alternative income, ongoing savings, and the collective wisdom of experienced caregivers. | New York | NY | 5 - 10 | 2023 | $1,110,000 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
Selera Medical is developing a device-based treatment for heart failure, to treat fluid overload in heart failure patients with a one-time, minimally invasive procedure | Mountain View | CA | 2 - 10 | 2023 | $500,000 |
We believe that everyone should have access to the healthcare they need, at a reasonable and transparent cost. We've built a platform which uses data to help employees save money on great healthcare options, from finding the right doctor, to saving money on prescription drugs, to fighting incorrect healthcare bills. | New York | NY | 10 - 50 | 2023 | $4,800,000 |
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DANNCE will help clinicians see the unseeable and drug developers generate real world evidence by using movement data and computer vision. | Boston | MA | 5 - 10 | 2023 | $2,600,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | Auburndale | MA | 20 - 50 | 2023 | $36,200,000 |
Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. | Salt Lake City | UT | 10 - 50 | 2023 | $57,295,000 |
Sylke is a healthcare products manufacturing company that offers silk fibroin adhesive wound closure. | 20 - 50 | 2023 | $15,531,995 | ||
Tandem Health focuses on providing care, whereas Tandem allows you to conveniently make medical notes immediately following the patient session. Tandem Health creates technologies that simplify administration in healthcare. | 20 - 100 | 2023 | |||
Century Health accelerates drug development and commercialization by applying AI to real-world data. It is far too slow today to answer critical questions because the richest clinical data is locked away in silos. Our platform does the heavy lifting to rapidly get you the insight you need, all while supporting the research community and protecting patient privacy. | Miami | FL | 10 - 50 | 2023 | $2,000,000 |
In-House Health is an AI-powered technical platform for modern nursing teams. | Denver | CO | 10 - 50 | 2023 | $4,000,000 |
UnityAI uses AI to enhance the management of hospital beds, optimize resource allocation, and elevate the quality of patient care. | Nashville | TN | 5 - 20 | 2023 | $4,000,000 |
Biowound Solutions is a healthcare company that develops and offers treatment product for chronic wounds. | Las Vegas | NV | 1 - 10 | 2023 | $4,510,000 |
Sohar Health is a platform for behavioral health companies. It is an API-based solution to handle eligibility verification, and AI-powered medical coding to automate manual workflows, increase patient intake, and generate more revenue | New York | NY | 1 - 10 | 2023 | $7,537,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,508 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 87 | 2023 | $1,100,999,936 |
Ti sento means “I hear you" in Italian. At Tisento Therapeutics, we believe that meaningful innovation requires understanding the problem, and that starts with listening. First and foremost, we listen to those impacted by debilitating diseases to understand the daily challenges they face. We also listen to healthcare providers, patient advocates, regulatory agencies, and scientific data. All these inputs inform our thinking and shape how we conduct our research, design our trials, and evolve our company. We are on a mission to deliver medicines that address what matters most. Our lead candidate is zagociguat (formerly CY6463), a Phase 2, first-in-class, brain-penetrant sGC stimulator, which is advancing in MELAS and other genetic mitochondrial diseases. Zagociguat is ideally suited to treat mitochondrial diseases with both CNS and peripheral symptoms, such as cognitive impairment, fatigue, and muscle weakness. | 10 - 50 | 2023 | $91,000,000 | ||
Switchboard Health helps payers, health systems, employers, and at-risk providers leverage virtual care solutions at scale. With our innovative technology and services, we activate people who need care, match them to the right provider, track the quality of their care, and support them across their entire care journey. | Boise | ID | 5 - 20 | 2023 | $8,749,999 |
Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells. | Lake Forest | IL | 20 - 50 | 2023 | $32,000,000 |
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients’ lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA) | Waltham | MA | 50 - 200 | 2023 | $275,000,000 |
Tandem Workforce was built because skilled talent shortages are a pressing reality, for employers and our economy. When businesses are struggling to find the talent essential to fulfill their core mission the impacts can be felt across our economy. Tandem Workforce helps employers by delivering a comprehensive set of innovative tools that allow companies to stand out and win in an increasingly competitive labor market. | New York | NY | 10 - 50 | 2023 | $3,000,000 |
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.